These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safer use of MAOIs with nifedipine to counteract potential hypertensive crisis. Hesselink JM Am J Psychiatry; 1991 Nov; 148(11):1616. PubMed ID: 1781863 [No Abstract] [Full Text] [Related]
3. Treatment of MAOI hypertensive crisis with sublingual nifedipine. Clary C; Schweizer E J Clin Psychiatry; 1987 Jun; 48(6):249-50. PubMed ID: 3584082 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic comparisons of oral and sublingual nifedipine in hypertensive Mexican patients. Palma-Aguirre JA; Roa-Mendieta A; Hernández-Jiménez LM; Girard-Cuesy ME; León-Urrea F; Alfaro-Mejía A; Frati A; Barreiro-Perera O Proc West Pharmacol Soc; 1993; 36():137-41. PubMed ID: 8378367 [No Abstract] [Full Text] [Related]
5. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy? Langton PE Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398 [No Abstract] [Full Text] [Related]
6. Safer use of MAOIs. Fier M Am J Psychiatry; 1991 Mar; 148(3):391-2. PubMed ID: 1992846 [No Abstract] [Full Text] [Related]
7. Sublingual nifedipine in the treatment of hypertensive crisis associated with monoamine oxidase inhibitors. Schenk CH; Remick RA Ann Emerg Med; 1989 Jan; 18(1):114-5. PubMed ID: 2910154 [No Abstract] [Full Text] [Related]
8. [The use of sublingual nifedipine in pediatric hypertensive patients at the Hospital de la Capital]. Marrero Arroyo D; Carrer MT; Molina M; Gómez M; Jiménez E Bol Asoc Med P R; 1991 Dec; 83(12):530-4. PubMed ID: 1811604 [TBL] [Abstract][Full Text] [Related]